Hurley D M, Hunter A N, Hewett M J, Stockigt J R
Aust N Z J Med. 1981 Aug;11(4):391-3. doi: 10.1111/j.1445-5994.1981.tb03519.x.
Atrial fibrillation or flutter was present in 70 of 381 patients with uncontrolled hyperthyroidism; return to stable sinus rhythm occurred in 39 with antithyroid and antiarrhythmic treatment. One third of the patients who reverted did so in the first week of treatment while still hyperthyroid. As expected, reversion was more likely in younger patients, and in those with arrhythmia of recent onset, without evidence of other heart disease. Eight patients with arrhythmia had proven (five) or probable (three) major arterial embolic episodes. Four of these eight patients died. Embolism tended to occur at an early stage, during uncontrolled hyperthyroidism, in patients with both atrial fibrillation and cardiac failure. These findings suggest that prophylactic anticoagulation may be appropriate in this high risk group, although more extensive studies are necessary before effective prevention of embolism can be claimed.
381例甲状腺功能亢进未得到控制的患者中,70例存在心房颤动或扑动;39例接受抗甲状腺及抗心律失常治疗后恢复为稳定的窦性心律。三分之一恢复窦性心律的患者是在治疗的第一周甲状腺功能仍亢进时发生的。正如预期的那样,年轻患者以及近期发生心律失常且无其他心脏病证据的患者更有可能恢复窦性心律。8例心律失常患者发生了确诊(5例)或可能(3例)的主要动脉栓塞事件。这8例患者中有4例死亡。栓塞倾向于在甲状腺功能亢进未得到控制的早期、同时合并心房颤动和心力衰竭的患者中发生。这些发现表明,在这个高危人群中预防性抗凝可能是合适的,尽管在能够声称有效预防栓塞之前还需要更广泛的研究。